Forbes September 3, 2024
GLP-1s are sweeping across America, on track to become one of the most widely used medications in American history. A recent study from KFF documents their meteoric rise: one in eight adults say they’ve taken a GLP-1 agonist, rising to one in five for adults ages 50-64.
These drugs are part of a class of prescription medications initially developed to treat Type 2 diabetes that mimic the naturally occurring hormones in our body that regulate blood sugar levels and appetite. As appetite suppressants, GLP-1s have also increasingly been used to treat obesity and facilitate weight loss. Two of the most common are Novo Nordisk’s Ozempic, for Type 2 diabetes, and Wegovy, a higher dose of the same active ingredient, for...
Today's Sponsors
Today's Sponsor